Beta Bionics, Inc. (BBNX) Cash from Investing Activities (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Cash from Investing Activities data on file, last reported at $21.8 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 112.19% year-over-year to $21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.2 million (up 120.06% YoY) and the FY2025 annual result came in at -$162.8 million, down 4583.69% from the prior year.
• Cash from Investing Activities advanced to $21.8 million in Q1 2026 per BBNX's latest filing, from $658000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $21.8 million in Q1 2026, with the low at -$179.1 million in Q1 2025.
• Average Cash from Investing Activities over 3 years is -$16.0 million, with a median of $6.2 million recorded in 2025.
• Year-over-year, Cash from Investing Activities tumbled 2443.3% in 2025 and soared 112.19% in 2026.
• Beta Bionics' Cash from Investing Activities stood at -$29.7 million in 2024, then surged by 102.22% to $658000.0 in 2025, then jumped by 3219.0% to $21.8 million in 2026.
• Business Quant data shows BBNX's Cash from Investing Activities at $21.8 million in Q1 2026, $658000.0 in Q4 2025, and $9.5 million in Q3 2025.